The AdnaTest® assay is an RT-PCR based test for detecting cancer-specific mRNA markers, e.g., GA733-2, MUC1, and HER2 for breast cancer, after immunomagnetic enrichment of tumor cells with MUC1 and EpCAM antibodies. Here, ERBB2 is linked to breast carcinoma.